High Prices For Biologics Abroad Serve Political Purpose In U.S. – AEI Report
Executive Summary
The high price of biologics in overseas markets could be the result of manufacturers' political considerations in the U.S., the authors of an American Enterprise Institute/Brookings Institution working paper suggest